ESR1 and breast carcinoma: The similarities between AR/ER signalling in prostate and breast cancer extend to mechanisms of therapy resistance; indeed, most therapy-resistant cases of BC and PC exhibit alterations to the AR/ER signalling axes that enhance oncogenic signalling [1,7,8].